Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Pieris Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.04
02.01.23
€3.00
31.12.25
-26.41%
05.05.23

Could be very worthwhile Investment >20% year
buy
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€5.94
02.01.23
€10.00
31.12.25
10.85%
05.05.23

Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€49.00
02.01.23
-
02.01.24
-72.35%
02.04.23

buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.18
01.01.23
-
01.01.24
77.98%
02.04.23

Could be very worthwhile Investment >20% year
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€5.62
31.12.22
€15.00
31.08.25
25.49%
05.05.23

Could be very worthwhile Investment >20% year
DEMIRE Deutsche Mittelstand Real Estate AG

Start price
Target price
Perf. (%)
€2.49
30.12.22
€1.00
30.12.23
-0.40%
07.01.23

Risky Investment
Deficits in Management
Very bad culture
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€7.86
29.12.22
€2.00
31.12.25
-2.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.15
28.12.22
-
28.01.26
-45.12%
11.03.24

Could be worthwhile Investment >10% per year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€61.20
28.12.22
-
28.01.26
-71.40%
11.03.24

Could be worthwhile Investment >10% per year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€9.33
27.12.22
-
27.12.23
-57.45%
06.01.23

Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.64
27.12.22
-
27.12.23
8.64%
24.04.23

Growths faster than the competition
Risky Investment
Codexis Inc.

Start price
Target price
Perf. (%)
€3.99
27.12.22
-
27.12.23
-6.46%
24.04.23

Probably not worthwhile Investment
buy
Bertrandt AG

Start price
Target price
Perf. (%)
€40.55
27.12.22
€55.00
22.07.23
17.26%
13.07.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
Fair valuation
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.75
26.12.22
-
26.12.23
48.74%
05.02.23

Risky Investment
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.15
26.12.22
-
26.12.23
200.63%
18.05.23

Could be very worthwhile Investment >20% year
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.27
26.12.22
-
26.12.23
111.45%
06.03.23

Could be worthwhile Investment >10% per year
buy
Meta Material Inc.

Start price
Target price
Perf. (%)
€1.03
26.12.22
-
03.03.23
9.95%
02.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Manitou BF S.A.

Start price
Target price
Perf. (%)
€23.70
24.12.22
-
24.12.23
-2.95%
25.12.23

Could be worthwhile Investment >10% per year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.33
24.12.22
€7.00
31.12.25
-8.10%
09.01.23

Could be very worthwhile Investment >20% year
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€5.09
24.12.22
€8.00
31.12.25
-45.23%
05.05.23

Could be very worthwhile Investment >20% year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.19
24.12.22
-
24.12.23
5.50%
25.12.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.81
24.12.22
-
24.12.23
-25.37%
01.11.23

Could be worthwhile Investment >10% per year
buy
Chargeurs

Start price
Target price
Perf. (%)
€14.21
24.12.22
-
24.12.23
-43.91%
03.11.23

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€14.28
24.12.22
-
24.12.23
-
24.12.22

Could be worthwhile Investment >10% per year